Legal
Filter News
Found 8,719 articles
-
U.S. District Court Orders FDA to Reconsider Application for Final Approval of BRIXADI™ (buprenorphine) Extended-Release Injection for the Treatment of Opioid Use Disorder
7/23/2019
Braeburn's application for final approval of BRIXADI is remanded back to FDA for reconsideration "with deliberate speed."
-
Shanghai Concord Medical Cancer Center has Accepted Medical Insurance Settlement from Patients from certain Yangtze River Delta Regions
7/23/2019
Concord Medical Services Holdings Limited announced that Shanghai Concord Medical Cancer Center has become a designated hospital in Shanghai, allowing the general outpatient services and the major outpatient services to be settled by medical insurance according to the standard of the local third-level hospitals.
-
Legal-Bay Pre Settlement Funding Preparing For Numerous Bayer Lawsuits
7/22/2019
The funding company reports the manufacturing giant is under fire for distributing faulty Essure birth control implants.
-
CVS-Aetna Merger: AHF Urges Court to Stop the '800-pound Gorilla'
7/21/2019
Friday, Judge Richard J. Leon of the U.S. District Court for the District of Columbia heard closing arguments from attorneys for the parties and also from several friends of the court (amicus curiae) opposed to the nearly $70 billion acquisition of Aetna by CVS Health.
-
TREVENA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Trevena, Inc. - TRVN
7/20/2019
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Trevena, Inc. (NasdaqGS: TRVN).
-
A three-judge panel ruled against Shkreli's appeals team, claiming that the trial judge's directions were clear and within the law.
-
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Helius Medical Technologies, Inc. - HSDT
7/18/2019
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Helius Medical Technologies, Inc. (NASDAQ: HSDT) from November 9, 2017 through April 10, 2019, inclusive (the "Class Period").
-
PIA National Praises House Passage of Bipartisan Repeal of Cadillac Tax
7/18/2019
The National Association of Professional Insurance Agents (PIA National) praised the overwhelming passage in the U.S. House of a bipartisan bill to repeal the provision of the Affordable Care Act (ACA) known to many as the "Cadillac Tax."
-
Newly Introduced Federal Legislation Puts Doctors and Patients Back in Control of Important Health Care Decisions
7/18/2019
AOA-backed "DOC Access Act" targets health and vision plan abuses; improves quality and access for millions of patients
-
Release of Federal Database Reveals 76 Billion Opioid Pills Were Sold in the U.S. From 2006-2012
7/17/2019
A federal judge ordered that information on sales of opioids up to the year 2013 could be released. -
CDNA INVESTIGATION ALERT: Hagens Berman Alerts CareDx (CDNA) Investors to Investigation of Possible Disclosure Violations
7/17/2019
Hagens Berman Sobol Shapiro LLP notifies investors in CareDx, Inc. of the firm's investigation of possible disclosure violations.
-
In November 2018, Chinese researcher He Jiankui announced he had used CRISPR gene editing to modify the CCR5 genes in the embryos of seven Chinese couples. This was met by widespread condemnation, investigations and a call for a global moratorium against that type of research.
-
Treat and Reduce Obesity Act Gains Support in the U.S. House of Representatives in Record Time
7/16/2019
The 2019 Treat and Reduce Obesity Act (TROA) (S595) (HR1530) has surpassed 100 co-sponsors in the U.S. House of Representatives with a total of 112 legislators supporting the Act.
-
United States Patent and Trademark Office Issues U.S. Patent Covering an Enhanced Formulation of Pliaglis
7/16/2019
In April 2017, Crescita announced that it had entered into a development and commercialization license agreement with Taro Pharmaceuticals Inc.
-
Medicomp Systems Awarded Patent for Intelligent Filtering of Clinical Data
7/16/2019
Patented technology filters health data to provide clinicians with point-of-care access to relevant information for optimal decision-making
-
Mass. Nurses Association Reports: Department of Public Health Finds Baystate Noble and Wing ICUs 'Necessary for Preserving Access and Health' Following Closure Hearings
7/16/2019
Nurses, patients and advocates are also fighting to preserve Baystate mental health units in Greenfield, Palmer and Westfield
-
The Sackler family has earned billions from the sale of OxyContin and the backlash against the family has increased in-fighting, according to reports.
-
OMCL INVESTIGATION Update: Hagens Berman Updates Omnicell (OMCL) Investors of the Firm's Ongoing Investigation of Possible Disclosure Violations
7/15/2019
If you purchased or otherwise acquired OMCL securities on or before July 10, 2019 and suffered losses or have information that may assist the firm's investigation contact Hagens Berma
-
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ra Medical Systems, Inc. To Contact The Firm
7/12/2019
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ra Medical Systems, Inc. of the August 6, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
-
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm
7/12/2019
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Heron Therapeutics, Inc. or the of the August 5, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.